A

study reported that 745T and 1083C were associated with increased IFN-γ or IL-2 levels after BCG vaccination [84], but the mechanism is still unclear (Table 1). TLR8 is located on X chromosome and able to recognize single-stranded RNA from pathogens such as RNA viruses. According to the literature, Davila et al. [85] first reported TLR8 SNPs, and they have analysed 149 SNPs from Indonesian and Russian pulmonary TB patients, of these four SNPs were significantly associated with the pulmonary TB among Indonesian and Russian males. Three of the associated TLR8 variants are −129 C/G, −2167 A/G and −1145 A/G present in the regulatory regions, and one variant 1 A/G (Met1Val) at the start codon. Indonesian males were carriers of Met1Val, allele A showed an increased susceptibility to pulmonary TB, While G allele shows protection from TB. Another study reported in JAK2 inhibitor drug Turkish children [86] also showed an association with susceptibility to pulmonary TB among male children, but found no associations with −129 C/G SNP for TB susceptibility in children, whereas Davila et al. found a strong allelic association with minor allele C in susceptibility to pulmonary TB in males, but the mechanism through which

TLR8 recognizes M. tb and intracellular signalling remains unknown (Table 1). TLR9 composed of 2 exons and encodes 1032 amino acids [87]. It recognizes unmethylated CpG motifs in bacterial DNA. It Inhibitor Library cost was found to be essential for cellular responses to mycobacterial CpG DNA [88]. In vitro studies showed that DCs release IL-12 in response to M. tb through TLR9 [89, 90]. A report demonstrates that TLR9-deficient mice are susceptible to Mtb infection, and mice lacking both TLR2 and TLR9 are more susceptible [89] to TB. Four SNPs, C-1486T, C-1237T, G+1174A and G+2848A, have been reported to show high heterozygocity among three major US ethnic groups [91]. C-1237T, a polymorphism Alanine-glyoxylate transaminase located within the putative promoter region that may influence transcriptional regulation of the TLR9 gene.

SNP G+1174A, located in the intron of TLR9, showed a significant association with TB in Indonesian females [92]. Promoter polymorphisms, namely −1237C/T and −1486C/T, are not associated with pulmonary TB in south Indian population [93]. TLR9 activation is essential for the maintenance of M. tb Ag elicited pulmonary granulomatous response; however, the underlying mechanism is not known. SNPs in promoter region potentially affect gene expression levels by altering the binding of gene transcription factors and SNPs in introns, affecting mRNA splicing and/or enhancement of gene transcription. Carvalho et al. [94] reported that peripheral blood mononuclear cells (PBMCs) harbouring the -1237 TC genotype shown higher expression of both TLR9 and IL-6 and increased B-cell proliferation in response to CpG DNA, but the mechanism is not known (Table 1).

506). For SAP, C. albicans from NDOC showed the lower enzymatic activity (P < 0.001). There were no significant differences between isolates from HS and DOC (P = 0.7051). C. albicans isolates from NDOC and DOC patients showed an increased production of PL. "
“Candidaemia remains a relevant challenge in everyday patient care on intensive care units and general wards. Delays to adequate treatment

increase mortality rates and institutional standard operating procedures facilitate optimal treatment. A positive blood culture requires immediate treatment. Echinocandins are the first-line drugs selleck chemicals llc of choice. Indwelling catheters have to be removed if feasible. Daily blood cultures until persistently negative exclude ongoing fungaemia. In case of Candida parapsilosis antifungal therapy should be switched to intravenous fluconazole. After 10 days of intravenous either echinocandin or fluconazole treatment, step-down to oral application of fluconazole simplifies antifungal therapy. Depending on organ involvement and clinical presentation of the patient antifungal treatment should be continued for at least 14 days after the last positive blood culture. We present our institutional management algorithm for candidaemia which is based on current guidelines and recommendations to improve patient outcome. “
“We prospectively observed 36 haematological

patients with mucormycosis from nine hospitals of St. Petersburg during 2004–2013. The most buy Y-27632 frequent underlying diseases were acute leukaemia (64%), and main risk factors were prolonged neutropenia (92%) and lymphocytopenia (86%). In 50% of the patients, mucormycosis was diagnosed 1–65 days after invasive aspergillosis. Main clinical form of mucormycosis was pulmonary (64%), while two or more organ involvement was noted

in 50% of the cases. The most frequent aetiological agents of mucormycosis were Rhizopus spp. (48%). Twelve-week survival rate was 50%. Combination therapy (echinocandins + amphotericin B forms) and recovery from the underlying disease significantly improved the survival rate. Mucormycosis (zygomycosis) is a severe opportunistic infection. At present, an increased frequency of mucormycosis is noted worldwide, particularly in patients with haematological malignancies. This is not only due to improvement of diagnostic methods for fungal infections, but rather because of more aggressive schemes of cytostatic therapy Baf-A1 and more extensive use of haematopoietic stem cell transplantation. The range of underlying conditions in mucormycosis has changed. In the period 1980–1990, mucormycosis predominantly had developed in patients with decompensated diabetes mellitus. Over the last years, mucormycosis most frequently has been diagnosed in patients with haematological malignancies.[1, 2] We represent a clinical case of successful treatment of mucormycosis in a patient with acute myeloid leukaemia (AML), along with results of a prospective study of mucormycosis in haematological patients in St.

To calculate the relative inhibition of IFN-γ by Tregs, the difference between the expression MLN0128 levels of IFN-γ in the absence and presence CD25 cells was divided by the level of IFN-γ expression in the presence of CD25 cells. T cell absolute counts were defined using the TruCOUNT tubes and MultiSET software with a FACSCalibur cytometer (BD Biosciences). HIV-1 RNA level was determined from plasma using the Roche Amplicor 1.5 assay (Roche, Nutley, NJ, USA). All undetectable values (<400 copies) were assigned a value of 399. Statistical analysis was performed using analysis software SPSS 11.5 (Chicago, IL, USA). The data is presented as the median and 95% CI and

viral load was log-transformed. Mann–Whitney tests were used to compare differences between groups of individuals. Spearman’s tests were used to calculate the significance of correlation coefficients. Multivariate least-square regression

models were used to calculate the predictive strength of variables (CD4+ T cell count, viral load, activation of T cells) on one of two dependent variables, proportion or absolute count of Tregs. For all comparisons, P-values < 0.05 were considered to be statistically significant. HIV-infected SPs were found to have lower levels of CD4+CD25+Foxp3+ Tregs as a proportion of all CD4+ T cells (2.8%) than asymptomatic HIV-infected patients (4.4%), AIDS patients (5.8%), and normal controls (5.4%, Fig. 1a and b). Further IWR-1 in vivo analysis revealed that asymptomatic HIV-infected patients had a significantly lower

level of CD4+CD25+Foxp3+ Tregs when compared to the AIDS patients (Fig. 1a). We also analyzed the absolute number of CD4+CD25+Foxp3+ Tregs and found the absolute number of Tregs to be lowest among AIDS patients (6.58), with stepwise increases seen in asymptomatic HIV-infected individuals (13.91) to SPs (19.59) to normal controls (33.00; Fig. 1c), which is consistent with absolute CD4+ T cell counts in the four groups (Fig. 1d). We examined the relationships between the proportion of Tregs, CD4+ T cell counts, immune activation, and viral load. Spearman rank correlation coefficients showed that the proportion of Tregs was Vasopressin Receptor inversely correlated with CD4+ T cell counts (r=−0.509, P < 0.001, Fig. 2a) and positively correlated with HIV viral load (r= 0.414, P < 0.01, Fig. 2b). We measured the relationship between the proportion of Tregs with the percentage of CD4+CD38+ and CD8+CD38+ cells and the level of HLA-DR expression as measures of T cell activation. The percentage of CD4+CD38+ and CD8+CD38+ cells was found to be positively correlated (r= 0.286, P < 0.05, and r= 0.245, P < 0.05, respectively, Fig. 2c and d), while the level of HLA-DR was found to have no correlation. T cell activation data are shown in Table 2.

Seven successive questions, numbered from 1 to 7 in the IPSS, were divided into two groups. These consisted of questions 1, 3, 5, and 6 and questions 2, 4, and 7, that represented voiding and storage symptoms, respectively.

If the mean voiding symptom score, defined as the summation score of questions 1, 3, 5, and 6, divided by 4 ([sum of scores for questions 1, 3, 5, and 6]/4) was greater than the mean storage symptom score ([sum of scores for questions 2, 4, and Autophagy activator 7]/3), then the patients were included in the voiding LUTS group. Otherwise, they were considered to be in the storage LUTS group.[16] The patients’ medical histories were obtained, and physical examinations, including neurological examination, were performed. Complete blood count, prostate specific antigen (PSA), glucose, creatinine, and liver enzyme analyses, urinalysis, and uroflowmetry were performed on the patients as well. Prostate volume and post-micturitional volume were assessed with ultrasonography. Ultrasound-guided needle biopsies were performed in cases where there was a suspected

malignancy (e.g., elevation of PSA > 4, suspicion of malignancy on digital rectal examination). Exclusion criteria were as follows: (i) any condition that can disrupt brainstem reflex, such as cranial nerve lesions, cerebrovascular disease, disease associated with neuropathy, BGB324 or being treated with drugs recognized as potentially causing neuropathy, (ii) abnormal findings in the neurological examination, (iii) abnormal findings on brain MRI scan (iv) medical treatment for Cobimetinib price LUTS, (v) signs of cancer of the urinary tract, (vi) history of pelvic surgery, (vii) any alcohol usage, or (viii) any abnormality determined by the blood and urine analysis listed above. Of the 32 patients, 16 had mean storage symptom scores that were higher than their mean voiding symptom scores and peak flow rates higher than 15 mL/sec. These patients had frequency and nocturia that was

greater than 7 and 1, respectively. All of the patients in the storage LUTS group had urge incontinence. The other 16 patients had mean voiding symptom scores that were higher than their mean storage symptom scores and peak flow rates lower than 10 mL/sec. All of the patients had previously provided a urination pattern detailing the time and volume of each urination over at least 3 days. The afferent limb of the blink reflex travels in the ophthalmic division of the trigeminal nerve, known as the supraorbital nerve. The supraorbital nerve can be stimulated by surface electrodes during EMG. The facial nerve subserves the efferent limb and contracts the orbicularis occuli muscle (Fig. 1). The blink reflex responses from the inferior portion of both orbicularis oculi muscles may be recorded simultaneously, through surface electrodes, during EMG. While the EMG was being recorded, patients were supine on a bed, in a warm room, with their eyes slightly closed.

In this context, facilitation of the clearance of GXM by treatment with protective antibodies [53] could limit the deleterious effect produced by soluble GXM. These results highlight a novel mechanism of immunosuppression which partly explains the dysregulation of immune responses accompanying cryptococcal infection. This study was funded by the European Commission: FINSysB Marie Curie Initial Training 16 Network, PITN-GA-2008-214004; and the National Health Institute: SPAL09AVEC. We thank Catherine Macpherson for editorial assistance. There are no financial and commercial conflicting interests. click here “
“The diseases caused by trypanosomes are medically and economically devastating to

the population of Sub-Saharan Africa. Parasites of the genus Trypanosoma infect both humans, causing African sleeping sickness, and livestock, causing Nagana. The development of effective treatment strategies has Selleckchem Dasatinib suffered from severe side effects of approved drugs, resistance and major difficulties in delivering drugs. Antimicrobial peptides (AMPs) are ubiquitous components of immune defence and are being rigorously pursued as novel sources of new therapeutics for a variety of pathogens. Here, we review the role of AMPs in the innate immune response of the tsetse fly to African trypanosomes, catalogue trypanocidal AMPs from diverse organisms and highlight the susceptibility of bloodstream

form African trypanosomes to killing by unconventional toxic peptides. African trypanosomes are the Casein kinase 1 causative agents of human African trypanosomiasis (HAT), also known as sleeping sickness, and Nagana, a wasting disease of livestock (1). The parasites that infect humans are subspecies of Trypanosoma brucei, Trypanosoma brucei gambiense and Trypanosoma brucei rhodesiense. The subspecies Trypanosoma brucei brucei causes livestock disease as well as Trypanosoma

vivax, Trypanosoma congolense and Trypanosoma evansi. Trypanosomiasis is a medical and socioeconomic burden primarily to Sub-Saharan Africa; however, T. vivax has been introduced into South America (2). Treatment is difficult for many reasons including the logistics of drug delivery and dosage requirements in impoverished rural areas, severe side effects, lack of overlapping drug effectiveness against T. b. gambiense or T. b. rhodesiense and the need to cross the blood–brain barrier to treat advanced HAT. The lifecycle of African trypanosomes involves several morphologically and physiologically distinct stages in both a mammalian and insect host, specifically flies of the genus Glossina, also known as tsetse flies. To survive within different hosts and also within significantly different tissue environments of the same host, the parasite has evolved physiological strategies to acquire nutrients and evade destruction by host immune factors.

sigmodontis infection. As BTK inhibitor mouse a first approach to dissect the role of the different IL-10-producing cell types in suppressing L. sigmodontis-specific Th1 and Th2 immune responses, we used mice with targeted B-cell-specific (IL-10FL/FL CD19-Cre) and CD4+ T-cell-specific (IL-10FL/FL CD4-Cre) deletion of the IL-10 gene [23, 24]. The immune response provoked by natural L. sigmodontis infection in mice lacking either T-cell-derived or B-cell-derived IL-10 was analyzed at days 17, 30, or 60 p.i. Recording L. sigmodontis

Ag-specific Th1 and Th2 responses, we observed that IL-10 deficiency in CD4+ T cells resulted in increased production of both, Th1-associated IFN-γ and Th2-associated IL-5 plus IL-13 responses to L. sigmodontis Ag at day 17 as an early time point of infection and at day 60 p.i. as a late time point of infection (Fig. 2A). Increased cytokine production was also observed upon polyclonal T-cell stimulation by anti-CD3 in CD4+ T-cell-specific IL-10−/− mice. CD19+ B cells represented a major source of L. sigmodontis-specific IL-10 during infection (Fig. 2, days 17 and 60). Interestingly, this B-cell-derived IL-10 was not mediating suppressive Small Molecule Compound Library effects, since B-cell-specific IL-10 deficiency did not induce statistically significant changes in L. sigmodontis Ag-specific

cytokine responses throughout infection (Fig. 2A). Polyclonal T-cell stimulation resulted in comparable, but low proliferation in splenocytes derived from all groups at day 60 p.i. L. sigmodontis Ag-specific proliferation was detectable pheromone in WT mice, while increased by trend in mice lacking IL-10 in T cells and decreased by trend in mice lacking IL-10 in B cells. However, these changes were not statistically significant (Fig. 2B). To rule out that the increased cytokine production observed in T-cell-specific IL-10−/− mice was due to changes in the cellular composition, we analyzed spleens at day 60 p.i. We did not record

significant changes in number and frequency of CD19+ B cells (Supporting Information Fig. 1A). We observed a decreased number and frequency of all T cells including CD4+Foxp3+ regulatory T cells, CD4+ T cells, and CD8+ T cells in spleens derived from T-cell-specific IL-10−/− mice (Supporting Information Fig. 1B). Therefore, increased Ag-specific proliferation and cytokine production in these mice was initiated by an even lower number of CD4+ T cells. The number and frequency of DX5+CD3− NK cells or DX5+CD3+ NKT cells were unchanged in all strains (Supporting Information Fig. 1C). Neither B-cell- nor T-cell-specific IL-10 deficiency induced statistically significant changes in the humoral response (Supporting Information Fig. 2). Taken together, our results indicate that specifically T-cell-derived IL-10 interfered with L. sigmodontis-specific Th1 and Th2 responses. B-cell-derived IL-10 was not central for initiating L.

[2] Macrophages

originate from circulating peripheral-blood monocytes that differentiate from common myeloid progenitors (CMP) in the bone marrow, which are also the common precursor for neutrophils, eosinophils, basophils, macrophages, DCs and mast cells. The haematopoietic growth factor colony-stimulating factor (CSF)-1 primarily controls the differentiation, maturation and survival of monocytes and macrophages. JQ1 nmr In response to CSF-1, monocytes differentiate from CMPs via the granulocyte/macrophage progenitor and macrophage/DC progenitor (MDP). Subsequently, these progenitors give rise to monoblasts, pro-monocytes and ultimately monocytes that are released into the circulation before entering tissues https://www.selleckchem.com/products/NVP-AUY922.html to become resident tissue macrophages. Most

tissues and organs harbour a resident macrophage population that plays an important role in tissue homeostasis from their functional role in phagocytosis and matrix remodelling. However, there is growing evidence that monocytes can also differentiate into DCs depending upon the surrounding tissue microenvironment. This is particularly evident in non-lymphoid organs such as the kidney, where there is considerable phenotypic and functional overlap between macrophage and DC populations. Monocytes represent a heterogeneous population of cells and constitute approximately 10% and 4% of leukocytes in humans and mice, respectively.[3] Monocyte heterogeneity was initially discovered in humans over 20 years ago based on the differential expression of the antigenic markers CD14 and CD16.[4] This enabled the categorization of

human monocytes into three major subsets: CD14hiCD16−, CD14+CD16+ and CD14dimCD16+ cells (Table 1).[4, 5] CD14hiCD16− monocytes /www.selleck.co.jp/products/Fasudil-HCl(HA-1077).html are referred to as ‘classical’ because their phenotype resembles the original description of monocytes, representing approximately 90% of total peripheral blood monocytes in a healthy person.[4, 6] In contrast, CD14+CD16+ monocytes, termed ‘non-classical’, constitute less than 10% of the total monocyte population and are phenotypically smaller and less dense. In patients with acute inflammation[7] and infectious diseases,[8, 9] monocyte numbers are significantly increased. Consequently, Grage-Griebenow et al.[5] identified an additional CD16+ monocyte population with reduced CD14 expression termed CD14dimCD16+ ‘intermediate’ monocytes. These monocytes represent approximately 5% of total blood monocytes and are functionally distinct from the CD14+CD16+ subset, with low phagocytic activity and high pro-inflammatory cytokine production, particularly tumour necrosis factor-α (TNF-α) and interleukin (IL)-1.

Albumin activated the canonical NF-kB pathway as demonstrated by the increased nuclear translocation of the NF-kB p65 and p50 subunits and the transcriptional factors activity. These events of canonical NF-kB activation were partially suppressed by BMP-7. Albumin induced apoptosis in PTEC as evidenced by the up-regulated apoptotic index from the TUNEL assay and the increased caspase-8 activity. Interestingly, addition of BMP-7 further exaggerated these apoptotic events in PTEC overloaded with albumin. Conclusion: Our results demonstrated that BMP7 exaggerated the apoptotic events induced

by albumin in cultured PTEC. This amplification of the albumin-induced apoptosis was associated with the reduction of TNF-α synthesis and canonical NF-kB pathway activation. This study is supported by a General Research Fund of the Research Grants Council (#HKU 7770/09M) of Hong Kong and Matching Grant Fulvestrant purchase from The University of Hong Kong. KODA RYO1,

YOSHINO ATSUNORI1, IMANISHI YUJI1, KAWAMOTO SHINYA1, UEDA YOSHIHIKO2, YAOITA EISHIN3, KAZAMA JUNICHIRO JAMES4, NARITA ICHIEI4, TAKEDA TETSURO1 1Department of Nephrology, Dokkyo Medical University Koshigaya Hospital; 2Department of Pathology, Dokkyo Medical University Koshigaya Hospital, Japan; 3Department of Structural Pathology, Institute of Nephrology, Graduate School of Medical and Dental Sciences, Japan; 4Division of Clinical Nephrology and NVP-LDE225 datasheet Rheumatology, Niigata University Graduate School of Medical and Dental Science, Japan Introduction: The origin of crescent forming cells in human glomerulonephritis

(GN) remains unknown. Some animal studies demonstrated that parietal epithelial cells of Bowman’s capsule C-X-C chemokine receptor type 7 (CXCR-7) (PECs) were the main component of proliferating cells and PEC-specific tight junction protein claudin-1 was expressed in crescentic lesions. Methods: We investigated the expression of claudin-1 in human GN. Immunohistochemistry for claudin-1 was performed on 17 kidney biopsy samples with crescent formation. Co-localization of claudin-1 with intracellular tight junction protein ZO-1 was evaluated by immunofluorescence double staining. Expression of occludin, another fundamental intercellular tight junction protein, was also evaluated in crescentic lesion in human glomerulonephritis. Results: Claudin-1 is expressed mainly at the cell to cell contact site of proliferating cells in cellular crescentic lesions in patients with these forms of human GN. Small numbers of crescent forming cells showed extra-junctional localization of claudin-1. Co-localization of claudin-1 with ZO-1 was found at cell to cell contact sites of adjacent proliferating cells. In control samples, staining of claudin-1 was positive in PECs, but not in podocytes. Conclusion: Our findings suggest that claudin-1 contributes to crescent formation as a component of the tight junction protein complex that includes ZO-1.

As described below, repeated measures of spleen volume and cell content were made TSA HDAC in four inoculated calves whereas change in regional distribution of phenotyped cells was determined by sequential euthanasia of six inoculated calves in comparison with two un-inoculated calves. Magnetic resonance imagery was performed with a 1·0 Tesla machine (Philips Intera, Andover, MA, USA). Sequences were acquired in a dorsal plane. The area imaged was from the spine to the ventral abdominal wall. A 40 cm field-of-view ensured that the entire spleen could be visualized. One-centimetre-thick

slices with a 2 mm gap were acquired using a short tau inversion recovery (STIR) sequence. This sequence resulted in a hyperintense spleen on a low intense background. The volume was calculated by tracing the outline of the spleen for the area on each slice and multiplying by the number of slices plus gap thickness

(3D-DOCTOR; Able Software Corporation, Lexington, MA, USA). Each calf’s spleen volume was calculated on the day prior to infection and then at 11 or 12 dpi, 2 calves each. Immediately following each MRI procedure, a 1 cm3 biopsy of marsupialized spleen was removed under local Sorafenib price lidocaine anaesthesia for determining differential cell counts. Each biopsy was immediately processed into a single cell suspension using a tissue grinder (Tenbroek; Bellco Glass, Inc., NJ, USA), suspended in 50 mL of PBS and enumerated for differential cell counts by standard methods used for whole blood (28). Six inoculated calves were euthanized by captive bolt and jugular exsanguination SSR128129E for collection

of spleen tissue: one calf each on dpi 7, 8, 9 (fever day 1) and 14 (fever day 5), and two calves at 13 dpi (fever days 4 and 5). In this way, the spleens from three calves each were examined from two periods: a period just prior to, or including, the initiation of fever (7, 8 and 9 dpi) and a period several days after fever initiation (13 and 14 dpi). Spleen tissue from two uninfected calves was similarly collected. Multiple 15 × 15 × 5 mm sections of spleen were collected from each calf immediately posteuthanasia. Each section was placed into a cryostat mould containing Tissue-Tek® O.C.T.™ Compound (Sakura Fineteck USA, Inc., Torrance, CA, USA), snap frozen by floating on liquid nitrogen, and stored at −80°C. Cryostat sections (15 μm) were mounted on standard SuperFrost™ Plus slides (Electron Microscopy Services, Hatfield, PA, USA), fixed in 95% EtOH for 10 min and allowed to air dry overnight at room temperature. Formalin-fixed, paraffin-embedded samples of spleen were also collected from each calf and routinely stained in haematoxylin and eosin (H&E). Immunolabelling was carried out at room temperature in a humidified chamber. A Super PAP Pen HT™ (Research Products International Corp., Mt. Prospect, IL, USA) was used to create a hydrophobic margin to retain fluid reagents on slides.

The aim of this post-hoc analysis was to investigate the effects of add-on therapy with calcium channel blockers (CCBs) on changes in the composite ranking of relative risk according to KDIGO guidelines. Benidipine, an L- and T-type CCB, and amlodipine, an L-type CCB to angiotensin MK-8669 datasheet II receptor blocker (ARB), were examined. Methods: Patients with blood pressure (BP) >130/80 mmHg, an estimated GFR (eGFR) of 30–90 mL/min/1.73 m2, and albuminuria >30 mg/gCr, despite treatment with the maximum recommended dose of ARB, were randomly assigned to two groups. Each group received one of

two treatments: 2 mg benidipine daily, increased to 8 mg daily (n = 52), or 2.5 mg amlodipine daily, increased to 10 mg daily (n = 52). Results: The final doses of benidipine and amlodipine were 6.3 ± 0.3 and 5.4 ± 0.4 mg per day, respectively. After 6 months of treatment, a significant SB203580 cell line and comparable reduction in systolic and diastolic BP was observed in both groups. The eGFR was significantly decreased in the amlodipine group, but there was no significant change in the benidipine group. The decrease in albuminuria in the benidipine group was significantly lower than in the amlodipine group. The composite ranking of relative risk according to the new KDIGO guidelines was significantly improved in the benidipine group; however,

no significant change Clomifene was noted in the amlodipine group. Moreover, significantly fewer cases in the benidipine group than the amlodipine group showed a reduced risk category score. Conclusion: The present post-hoc analysis showed that compared to

amlodipine benidipine results in a greater reduction in albuminuria accompanied by an improved composite ranking of relative risk according to the KDIGO CKD severity classification. TEO BOON WEE1,2, TOH QI CHUN1, LAU TITUS2, YANG ADONSIA1, LIN TINGXUAN1, SETHI SUNIL1,2 1National University of Singapore; 2National University Health System Introduction: Stable chronic kidney disease (CKD) patients retain sodium and water which increases intravascular fluid volume, leading to myocardial stretching and release of B-type natriuretic peptide (BNP). The profile of BNP levels in Asian CKD patients is unclear. We assessed serum BNP levels in a multiethnic-Asian population of stable CKD patients. Methods: We prospectively recruited stable CKD patient (defined as serum creatinine not >20% over 3 months) and performed anthropometry, office blood pressure measurements (Dinamap) according to practice guidelines, and venepuncture. Blood samples were assayed for BNP (Abbott), and creatinine to estimate glomerular filtration rate (eGFR) with the CKD-EPI equation. Data are reported as mean ± SD, or median and interquartile range, where appropriate. Non-normally distributed data were natural log-transformed for analyses.